Hannes Smárason chats with FierceBiotech about WuXi NextCODE's technology, products, investments and the road ahead.
The company's Owkin Socrates platform applies transfer and federated learning to clinical research.
The careful optimization of tumor-bearing humanized models leads to highly useful preclinical immuno-oncology platforms for accelerated immunotherapy…
Datavant will partner its 150 data sets with the three organizations' unique capabilities to drive clinical trial intelligence.
The new deal was built on the successful launch of Halaven and Fycompa in South Africa.
Eric Perakslis' experience with Takeda will help facilitate a new collaboration between the two companies.
Breakout Labs has backed over 30 companies since it handed out the first batch of grants in 2012.
Evotec will leverage its iPSC know-how with stem cell-based disease modeling to discover novel drugs for retinal diseases.
Parexel has relaunched its informatics solutions as Perceptive Cloud, the first milestone of the partnership with Microsoft.
X-Chem will screen its DNA-encoded libraries to discover novel antivirals for Gilead.
Enyo Pharma has successfully identified potential targets of its preclinical molecule series EYP002 with Charles River's technology.